DK0784476T3 - Behandling af multipel sklerose (MS) og andre demyelinisationstilstande under anvendelse af lofepramin i kombination med L-phenylalanin, tyrosin eller tryptophan og eventuelt en vitamin B12-forbindelse - Google Patents
Behandling af multipel sklerose (MS) og andre demyelinisationstilstande under anvendelse af lofepramin i kombination med L-phenylalanin, tyrosin eller tryptophan og eventuelt en vitamin B12-forbindelseInfo
- Publication number
- DK0784476T3 DK0784476T3 DK95933488T DK95933488T DK0784476T3 DK 0784476 T3 DK0784476 T3 DK 0784476T3 DK 95933488 T DK95933488 T DK 95933488T DK 95933488 T DK95933488 T DK 95933488T DK 0784476 T3 DK0784476 T3 DK 0784476T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenylalanine
- tyrosine
- combination
- multiple sclerosis
- lofepramine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9420116A GB9420116D0 (en) | 1994-10-05 | 1994-10-05 | A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions |
GBGB9508482.8A GB9508482D0 (en) | 1995-04-26 | 1995-04-26 | A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions, and the product |
PCT/GB1995/002361 WO1996011009A1 (en) | 1994-10-05 | 1995-10-05 | Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0784476T3 true DK0784476T3 (da) | 2003-03-17 |
Family
ID=26305745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95933488T DK0784476T3 (da) | 1994-10-05 | 1995-10-05 | Behandling af multipel sklerose (MS) og andre demyelinisationstilstande under anvendelse af lofepramin i kombination med L-phenylalanin, tyrosin eller tryptophan og eventuelt en vitamin B12-forbindelse |
Country Status (19)
Country | Link |
---|---|
US (2) | US6096737A (cs) |
EP (1) | EP0784476B1 (cs) |
JP (1) | JPH10508583A (cs) |
AT (1) | ATE227124T1 (cs) |
AU (1) | AU710339B2 (cs) |
CA (1) | CA2200761C (cs) |
CZ (1) | CZ293873B6 (cs) |
DE (1) | DE69528773T2 (cs) |
DK (1) | DK0784476T3 (cs) |
ES (1) | ES2184808T3 (cs) |
FI (1) | FI116659B (cs) |
HU (1) | HU225493B1 (cs) |
IS (1) | IS1956B (cs) |
NO (1) | NO314486B1 (cs) |
NZ (1) | NZ293642A (cs) |
PL (1) | PL181802B1 (cs) |
PT (1) | PT784476E (cs) |
SK (1) | SK281932B6 (cs) |
WO (1) | WO1996011009A1 (cs) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0942751T3 (da) * | 1996-07-05 | 2002-12-02 | Wwk Trust | Præparater til behandling af perifere nuropatier indeholdende antidepressiver og/eller monoaminoxidase-inhibitorer og/eller vitamin B12 og/eller prekursere til eller inducere af en neurotransmitter |
GB9617990D0 (en) | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
EP0835660A1 (en) * | 1996-10-14 | 1998-04-15 | Gaston Edmond Filomena Merckx | Products containing methylcobalamin for the treatment of multiple sclerosis or other demyelinating conditions |
US7232830B2 (en) * | 1998-06-26 | 2007-06-19 | Elaine A Delack | Method for treatment of neurodegenerative diseases and effects of aging |
GB9904252D0 (en) * | 1999-02-24 | 1999-04-21 | Worsley Andrew P | Composition for the treatment of pain |
GB9906808D0 (en) * | 1999-03-24 | 1999-05-19 | Kilgowan Limited | Formulation for treatment of pain |
GB2355191A (en) * | 1999-10-12 | 2001-04-18 | Laxdale Ltd | Combination formulations for fatigue, head injury and strokes |
WO2002011676A2 (en) * | 2000-08-04 | 2002-02-14 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
US20020147206A1 (en) * | 2001-04-05 | 2002-10-10 | Pfizer Inc. | Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy |
GB0216027D0 (en) | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US7169752B2 (en) * | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
US6833142B2 (en) * | 2002-03-14 | 2004-12-21 | Duane Bennett | Formulation for the prevention and treatment of multiple sclerosis and other demyelinating conditions |
EP1571970B1 (en) | 2002-10-02 | 2011-08-17 | DMI Biosciences, Inc. | Diagnosis and monitoring of diseases |
EP1599212A4 (en) * | 2003-02-14 | 2006-02-08 | Combinatorx Inc | POLYTHERAPY FOR THE TREATMENT OF IMMUNO-INFLAMMATORY DISORDERS |
WO2004103304A2 (en) * | 2003-05-15 | 2004-12-02 | Dmi Biosciences, Inc. | Treatment of t-cell mediated diseases |
GB0313630D0 (en) * | 2003-06-12 | 2003-07-16 | Wwk Trust The | Compositions for the enhanced treatment of depression |
TW200522932A (en) * | 2003-09-15 | 2005-07-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
ATE552832T1 (de) | 2006-02-24 | 2012-04-15 | Shire Llc | Antidepressivum-propharmaka |
EP2300011A4 (en) * | 2008-05-27 | 2012-06-20 | Dmi Life Sciences Inc | METHODS AND THERAPEUTIC COMPOUNDS |
WO2011011594A2 (en) * | 2009-07-23 | 2011-01-27 | Shriners Hospitals For Children | Intracellular toll-like receptors pathways and axonal degeneration |
JP2013537195A (ja) | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | 疾患の治療 |
KR102032400B1 (ko) | 2011-10-10 | 2019-10-15 | 앰피오 파마슈티컬스 인코퍼레이티드 | 퇴행성 관절 질환의 치료 |
CN103841934A (zh) | 2011-10-10 | 2014-06-04 | 安皮奥制药股份有限公司 | 增强免疫耐受的可植入的医疗装置及其制造与植入方法 |
EP2771007B1 (en) | 2011-10-28 | 2018-04-04 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
WO2014145729A2 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
EP4066836A1 (en) | 2014-08-18 | 2022-10-05 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
GB2544630A (en) | 2015-11-19 | 2017-05-24 | The Wwk Trust | Combinations for the treatment of dementia, and the enhancement of cognitive function |
CA3041358A1 (en) * | 2016-10-25 | 2018-05-03 | Uti Limited Partnership | Treatment for progressive multiple sclerosis |
EP3615053A4 (en) | 2017-04-25 | 2021-07-14 | Temple Otorongo LLC | PHARMACEUTICAL COMPOSITION CONSISTING OF TRYPTOPHAN AND A PHYLLOKININ DERIVATIVE FOR USE IN THE TREATMENT OF PSYCHIATRIC AND PSYCHOLOGICAL DISORDERS |
EP3431491A1 (en) * | 2017-07-18 | 2019-01-23 | Centre National De La Recherche Scientifique | Methods for purifying proteins having a tubulin carboxypeptidase activity and peptidic based inhibitors thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1497306A (en) * | 1975-07-03 | 1978-01-05 | Leo Ab | Preparation of lofepramine and its hydrochloride |
GB2082910A (en) * | 1980-08-28 | 1982-03-17 | Berk Pharmaceuticals Ltd | Anti-depressant compositions |
US4409243A (en) * | 1981-11-09 | 1983-10-11 | Julian Lieb | Treatment of auto-immune and inflammatory diseases |
GB2129299A (en) * | 1982-11-09 | 1984-05-16 | Alec James Coppen | Pharmaceutical compositions |
DE3519687A1 (de) * | 1985-06-01 | 1986-12-04 | Veit Arend | Aminosaeuren enthaltendes arzneimittel |
US4650789A (en) * | 1985-10-15 | 1987-03-17 | Commonwealth Medical Corporation Of America | Method and composition for increasing production of serotonin |
US4843071A (en) * | 1986-12-05 | 1989-06-27 | Serotonin Industries Of Charleston | Method and composition for treating obesity, drug abuse, and narcolepsy |
DE4204102C2 (de) * | 1992-02-12 | 1998-09-24 | Kragler Peter | Arzneimittel zur Behandlung und/oder Prophylaxe von AIDS und anderen verwandten Erkrankungen |
-
1995
- 1995-10-05 WO PCT/GB1995/002361 patent/WO1996011009A1/en active IP Right Grant
- 1995-10-05 EP EP95933488A patent/EP0784476B1/en not_active Expired - Lifetime
- 1995-10-05 NZ NZ293642A patent/NZ293642A/xx not_active IP Right Cessation
- 1995-10-05 DE DE69528773T patent/DE69528773T2/de not_active Expired - Lifetime
- 1995-10-05 AT AT95933488T patent/ATE227124T1/de not_active IP Right Cessation
- 1995-10-05 DK DK95933488T patent/DK0784476T3/da active
- 1995-10-05 JP JP8512415A patent/JPH10508583A/ja active Pending
- 1995-10-05 US US08/817,086 patent/US6096737A/en not_active Expired - Lifetime
- 1995-10-05 SK SK438-97A patent/SK281932B6/sk not_active IP Right Cessation
- 1995-10-05 PL PL95319830A patent/PL181802B1/pl not_active IP Right Cessation
- 1995-10-05 PT PT95933488T patent/PT784476E/pt unknown
- 1995-10-05 AU AU36126/95A patent/AU710339B2/en not_active Ceased
- 1995-10-05 ES ES95933488T patent/ES2184808T3/es not_active Expired - Lifetime
- 1995-10-05 CZ CZ1997995A patent/CZ293873B6/cs not_active IP Right Cessation
- 1995-10-05 CA CA002200761A patent/CA2200761C/en not_active Expired - Fee Related
- 1995-10-05 HU HU9702373A patent/HU225493B1/hu not_active IP Right Cessation
-
1997
- 1997-03-26 FI FI971290A patent/FI116659B/fi active IP Right Grant
- 1997-03-26 IS IS4454A patent/IS1956B/is unknown
- 1997-04-04 NO NO19971539A patent/NO314486B1/no not_active IP Right Cessation
-
2000
- 2000-06-01 US US09/584,401 patent/US6569850B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT784476E (pt) | 2003-03-31 |
US6569850B1 (en) | 2003-05-27 |
CA2200761A1 (en) | 1996-04-18 |
NO314486B1 (no) | 2003-03-31 |
AU710339B2 (en) | 1999-09-16 |
ATE227124T1 (de) | 2002-11-15 |
DE69528773T2 (de) | 2003-09-04 |
AU3612695A (en) | 1996-05-02 |
PL181802B1 (en) | 2001-09-28 |
NZ293642A (en) | 1998-10-28 |
SK43897A3 (en) | 1998-08-05 |
DE69528773D1 (de) | 2002-12-12 |
FI116659B (fi) | 2006-01-31 |
CA2200761C (en) | 2008-02-26 |
EP0784476A1 (en) | 1997-07-23 |
JPH10508583A (ja) | 1998-08-25 |
FI971290A0 (fi) | 1997-03-26 |
ES2184808T3 (es) | 2003-04-16 |
FI971290A (fi) | 1997-06-02 |
CZ99597A3 (en) | 1997-11-12 |
WO1996011009A1 (en) | 1996-04-18 |
NO971539L (no) | 1997-04-04 |
HUT77380A (hu) | 1998-04-28 |
IS4454A (is) | 1997-03-26 |
HU225493B1 (en) | 2007-01-29 |
SK281932B6 (sk) | 2001-09-11 |
PL319830A1 (en) | 1997-09-01 |
EP0784476B1 (en) | 2002-11-06 |
IS1956B (is) | 2004-11-15 |
CZ293873B6 (cs) | 2004-08-18 |
NO971539D0 (no) | 1997-04-04 |
US6096737A (en) | 2000-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0784476T3 (da) | Behandling af multipel sklerose (MS) og andre demyelinisationstilstande under anvendelse af lofepramin i kombination med L-phenylalanin, tyrosin eller tryptophan og eventuelt en vitamin B12-forbindelse | |
EA200001044A3 (ru) | Соединения для лечения женской сексуальной дисфункции | |
DK0942751T3 (da) | Præparater til behandling af perifere nuropatier indeholdende antidepressiver og/eller monoaminoxidase-inhibitorer og/eller vitamin B12 og/eller prekursere til eller inducere af en neurotransmitter | |
DK0869808T3 (da) | Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation | |
NO960339L (no) | Fremgangsmåte for å inhibere restenose | |
ES2144119T3 (es) | Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada. | |
BR9509807A (pt) | Composição líquida para administração oral e processo para tratar um mamífero incluindo o homem que esteja sofrendo de um quadro clinico mediado pela aç o do 5ht nos receptores 5ht3 | |
ATE252885T1 (de) | Plan zur verabreichung von h+, k+-atpase inhibitoren | |
DK0625050T3 (da) | TGF-BETA til forbedring af regenerering af nervevæv | |
DE69400631D1 (de) | Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose | |
BR0111158A (pt) | Composto e sais fisiológicos do mesmo, método para tratar uma condição mediana por tnf-a em um paciente | |
LV11728A (lv) | Farmaceitiska kompozicija | |
ES2175437T3 (es) | Composicion de enalapril y losartan. | |
ATE216891T1 (de) | Verwendung von immunosuppressiva zur behandlung der schizophrenie | |
DK0859630T3 (da) | Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer | |
DE69630761D1 (de) | Verfahren zur verminderung der renalen aufnahme von antikörperfragmenten | |
UA10928C2 (uk) | Спосіб профілактики гіперхолестериhемії | |
ATE138574T1 (de) | Verwendung von prostaglandin f3alpha als okulares hypotensivum | |
EA200101043A1 (ru) | Способ лечения неврологических или нейропсихиатрических расстройств | |
UA28288A (uk) | Спосіб лікування шизофренії | |
CO4700451A1 (es) | Dimaleato de n,n-dietil-8, 8-dipropil-2-azaspiro[4.5] decano-2-propanamina |